Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michele Johnson

Neurological Surgery Atlanta, GA Medical Doctor

NPI 1295861342 CMS profile 13785

2001 Peachtree Rd Ne, Suite 575, Atlanta, GA 30309

Open in the dashboard

General payments

$540,078

333 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michele Johnson of Atlanta, GA is reported in the CMS Open Payments database as having received $540,078 across 333 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $29,835 31
2024 General $21,360 14
2023 General $111,519 61
2022 General $146,303 66
2021 General $41,146 73
2020 General $34,565 24
2019 General $155,350 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michele Johnson
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Michele Johnson were reported at $29,835. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Michele Johnson Neurological Surgery median Middle half National median
2019 $155,350 $582 $138–$3,006 $163
2020 $34,565 $294 $76–$2,174 $114
2021 $41,146 $387 $105–$2,432 $132
2022 $146,303 $542 $139–$2,989 $149
2023 $111,519 $534 $145–$2,697 $160
2024 $21,360 $574 $155–$3,046 $164
2025 $29,835 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. NuVasive, Inc. $278,259 105 payments
  2. Globus Medical, Inc. $139,419 110 payments
  3. Medtronic, Inc. $90,732 63 payments
  4. Stryker Corporation $16,138 23 payments
  5. Medtronic USA, Inc. $14,651 12 payments
  6. DePuy Synthes Sales Inc. $210 5 payments
  7. Boston Scientific Corporation $164 2 payments
  8. MicroVention, Inc. $115 1 payment
  9. Ethicon US, LLC $113 1 payment
  10. Integra LifeSciences Corporation $60 2 payments
  11. Other $217 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $225,000 4 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $147,111 17 payments
  3. Consulting Fee $116,138 41 payments
  4. Travel and Lodging $43,395 129 payments
  5. Food and Beverage $8,434 142 payments
Products named General payments · program years 2019–2025
  1. Pulse Spine/Spine Surgery $107,169 28 payments
  2. Pulse Spine/Spine Surgery $59,087 29 payments
  3. CD HORIZON SPINAL SYSTEM $54,154 28 payments
  4. STEALTHSTATION S8 PLATFORM $18,046 17 payments
  5. SERRATO $15,024 9 payments
  6. AERO $15,024 9 payments
  7. RISE-L $14,962 7 payments
  8. TRITANIUM $14,855 15 payments
  9. CD HORIZON $14,479 10 payments
  10. ES2 $14,135 7 payments
  11. Other $124,715 185 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

206

Median for Neurosurgery: 83

Drug cost

$2,444

Median for Neurosurgery: $872

Branded share of claims

27.7%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 57 $915
Methocarbamol Generic 56 $611
Diclofenac Sodium Generic 19 $366
Gabapentin Generic 29 $330
Methylprednisolone Generic 18 $102
Tizanidine Hcl Generic 13 $82
Diazepam Generic 14 $39

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$94,927

Medicare's payments for the services billed

Medicare patients

139

Average age 72

Services billed

393

84 women, 55 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 37%
Diabetes 29%
Chronic kidney disease 27%
Depression 26%
Cancer 19%
Osteoporosis 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

333 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record